Drugs standards group nixes plan to kick pharma's crab blood habit
May 30, 2020 at 11:42 AM EDT
Horseshoe crabs' icy-blue blood is set to remain the drug industry's standard for safety tests after a powerful U.S. group ditched a plan to put on an equal footing a synthetic substitute pushed by Swiss biotech Lonza and animal welfare groups.